AC
REGN icon

AXQ Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

AXQ Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.84M Buy
+2,952
New +$2.01M 0.2% 153
2025
Q4 		– Sell
-1,223
Closed -$688K – 905
2025
Q3 		$688K Sell
1,223
-318
-21% -$180K 0.26% 111
2025
Q2 		$809K Buy
1,541
+852
+124% +$476K 0.26% 118
2025
Q1 		$437K Buy
689
+307
+80% +$211K 0.18% 219
2024
Q4 		$272K Sell
382
-873
-70% -$733K 0.12% 274
2024
Q3 		$1.32M Buy
+1,255
New +$1.4M 0.4% 71
2024
Q2 		– Sell
-300
Closed -$289K – 678
2024
Q1 		$289K Sell
300
-600
-67% -$571K 0.07% 439
2023
Q4 		$790K Buy
+900
New +$741K 0.21% 172

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

AXQ Capital's REGN Position: Q2 2026 in Review

AXQ Capital opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 2,952 shares worth $1.84M. The stake represents 0.2% of the portfolio and ranks #153 among its holdings. This is a return to the name: AXQ Capital previously reported a position in REGN as recently as Q3 2025.

AXQ Capital first reported a position in REGN in Q4 2023 and has held it in 8 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • AXQ Capital held 2,952 shares of Regeneron Pharmaceuticals worth $1.84M as of Q2 2026.
  • Regeneron Pharmaceuticals was a new AXQ Capital position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.2% of AXQ Capital's portfolio in Q2 2026, its #153 holding.
  • AXQ Capital first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.